Harmony Biosciences Holdings (HRMY)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total assets US$ in thousands 999,200 928,135 858,383 846,985 811,448 777,766 760,183 715,092 673,870 643,464 505,034 464,005 433,443 391,092 359,695
Total stockholders’ equity US$ in thousands 659,155 596,804 538,583 515,394 466,992 481,332 485,172 443,041 402,838 343,884 246,533 214,503 186,507 152,018 126,551
Financial leverage ratio 1.52 1.56 1.59 1.64 1.74 1.62 1.57 1.61 1.67 1.87 2.05 2.16 2.32 2.57 2.84

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $999,200K ÷ $659,155K
= 1.52

The financial leverage ratio of Harmony Biosciences Holdings has shown a decreasing trend over the analyzed period. Starting at 2.84 in June 2021, the ratio has steadily declined to 1.52 by December 2024. This indicates that the company has been reducing its reliance on debt financing in relation to its equity, reflecting a stronger financial position and potentially lower financial risk. The decreasing trend suggests that Harmony Biosciences Holdings has been effectively managing its capital structure and debt levels over time.